Company Email Format

OncoSenX

Biotechnology Research Seattle, Washington, United States 9 employees

Employees: 9
Contacts: 2
Emails: 2
Phones: 1

oncosenx.com LinkedIn Crunchbase

OncoSenX Overview

Headquarters: Seattle, Washington, United States
Website: oncosenx.com
Industry: Biotechnology Research
Employees: 9
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

About OncoSenX

OncoSenX is a late stage pre-clinical cancer company headquartered in Seattle, Washington. OncoSenX targets solid tumors based on transcriptional activity using a unique lipid nanoparticle and plasmid DNA. The next generation in cancer therapies will be more targeted with less side effects. At OncoSenX we believe the battle against cancer should be fought with genetic information. Our treatment delivers a simple program that induces apoptosis in cancerous cells. Our approach is a less invasive, more precise intervention for this complex and devastating disease.

OncoSenX Contact Details

People in AeroLeads: 4
With contact data: 2
Email contacts: 2; 50.0% coverage
Phone contacts: 1; 25.0% coverage

OncoSenX Org Chart

Sample employees and titles

Name	Title	Location	Contact
John Lewis	Bird Dogs Chair in Translational Oncology at University of Alberta	Edmonton, Alberta, Canada	Email
Eric Garcia			View
Ben Kong	Founder First Block Ventures, Angel Investor in 100+ Companies. Space, Biotech, Web 3, Metaverse, Nft		View
Matthew Scholz	Founder and Chief Executive Officer at Oisín Biotechnologies	Seattle, Washington, United States	Email Phone